{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:08:43Z","timestamp":1788570523158,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.04.086","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T19:15:19Z","timestamp":1462302919000},"page":"3310-3316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use"],"prefix":"10.1016","volume":"34","author":[{"given":"Jehanara","family":"Korimbocus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dehay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Tordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Morgeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.04.086_bib0365","series-title":"Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses","first-page":"654","article-title":"Rhabdoviridae","author":"Dietzgen","year":"2011"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0370","series-title":"WHO Expert Consultation on rabies","year":"2013"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0375","unstructured":"EC Administrative Procedure for Official Control Authority Batch Release: Control authority batch release of vaccines and blood products. Council of Europe. PA\/PH\/OMCL (09) 28 DEF."},{"key":"10.1016\/j.vaccine.2016.04.086_bib0380","series-title":"Technical Report Series 413: Requirements for immune sera of animal origin","first-page":"45","author":"WHO","year":"1969"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0385","unstructured":"Official Authority Batch Release of Human Immunoglobulin Guideline. Council of Europe. PA\/PH\/OMCL (13) 80 DEF."},{"key":"10.1016\/j.vaccine.2016.04.086_bib0390","series-title":"Laboratory techniques in rabies","article-title":"Quantitative assay and potency test of antirabies serum and immunoglobulin","author":"Atanasiu","year":"1973"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0395","series-title":"Laboratory techniques in rabies","first-page":"417","article-title":"Potency test of rabies antiserum and immunoglobulin","author":"Fitzgerald","year":"1996"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0400","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"A rapid reproductible test for determining rabies neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0405","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0092-1157(85)80031-7","article-title":"Application d\u2019une m\u00e9thode immuno-enzymatique au titrage des anticorps rabiques neutralisants en culture cellulaire","volume":"13","author":"Perrin","year":"1985","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0410","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN) for the quantification of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0415","unstructured":"European Pharmacopoeia Human Rabies Immunoglobulin; 01\/2008. p. 2431."},{"key":"10.1016\/j.vaccine.2016.04.086_bib0420","series-title":"Replacement, reduction and refinement of animal experiments in the development and control of biological products","first-page":"31","article-title":"WHO activities towards the three Rs in the development and control of biological products","author":"Milstien","year":"1996"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0425","first-page":"21","article-title":"Contributions of the European OMCL network and biological standardisation programme to animal welfare","volume":"23","author":"Behr-Gross","year":"2006","journal-title":"Altex"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0430","first-page":"33","article-title":"Directive 2010\/63\/EU of the European Parliament and the Council of 22 September 2010 on the protection of animals used for scientific purposes","volume":"L276","year":"2010","journal-title":"Off J Eur Union"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0435","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.109.3.464","article-title":"Radioimmunoassay procedure for rabies binding antibodies","volume":"109","author":"Wiktor","year":"1972","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0440","first-page":"489","article-title":"Epreuve immuno-enzymatique pour la d\u00e9tection rapide des anticorps rabiques","volume":"128","author":"Atanasiu","year":"1977","journal-title":"Ann Microbiol (Inst Pasteur)"},{"issue":"8034","key":"10.1016\/j.vaccine.2016.04.086_bib0445","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(77)90321-X","article-title":"Enzyme immunoassay for demonstration of rabies virus antibodies after immunisation","volume":"2","author":"Thraenhart","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0450","first-page":"207","article-title":"Use of an enzyme immunoassay with protein A for rabies antigen and antibody titration","volume":"46","author":"Atanasiu","year":"1980","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0455","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jmv.1890090107","article-title":"Enzyme-linked immunosorbent assay: a rapid reproductible test for the measurement of rabies antibody","volume":"9","author":"Nicholson","year":"1982","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0460","first-page":"422","article-title":"Enzyme-linked immunosorbent assay for quantification of rabies antibodies in human sera","volume":"28","author":"Kavaklova","year":"1984","journal-title":"Acta Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.04.086_bib0465","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0092-1157(86)90027-2","article-title":"The influence of the type of immunosorbent on rabies antibody EIA: advantages of purified glycoprotein over whole virus","volume":"14","author":"Perrin","year":"1986","journal-title":"J Biol Stand"},{"issue":"5","key":"10.1016\/j.vaccine.2016.04.086_bib0470","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/JCM.27.5.899-902.1989","article-title":"Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus","volume":"27","author":"Grassi","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.04.086_bib0475","doi-asserted-by":"crossref","DOI":"10.1590\/S0036-46651999000100008","article-title":"An ELISA suitable for the detection of rabies virus antibodies in serum samples from human vaccinated with either cell-culture vaccine or suckling-mouse-brain vaccine","volume":"41","author":"Piza","year":"1999","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0480","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0264-410X(02)00188-3","article-title":"Antibody responses induced by immunisation with a Japanese rabies vaccine determined by neutralisation test and enzyme-linked immunosorbent assay","volume":"20","author":"Arai","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0485","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2009.05.018","article-title":"Development and evaluation of a rapid neutralizing antibody test for rabies","volume":"161","author":"Shiota","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0490","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1016\/j.vaccine.2012.06.037","article-title":"Evaluation of a new serological technique for detecting rabies virus antibodies following vaccination","volume":"30","author":"Ma","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0495","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0166-0934(94)00098-2","article-title":"A liquid-phase blocking ELISA for the detection of anti-rabies to rabies virus","volume":"51","author":"Esterhuysen","year":"1995","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0500","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1292\/jvms.61.411","article-title":"A new quantitative method for rabies virus by detection of nucleoprotein using ELISA","volume":"61","author":"Katayama","year":"1999","journal-title":"J Vet Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2016.04.086_bib0505","doi-asserted-by":"crossref","DOI":"10.1590\/S0074-02762004000500013","article-title":"Rabies neutralizing antibody detection by indirect immuno-peroxidase serum neutralisation assay performed on chicken embryo related cell line","volume":"99","author":"Cardoso","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0510","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/CVI.00102-06","article-title":"A novel double-antigen sandwich enzyme-linked immunosorbent assay for measurement of antibodies against rabies virus","volume":"13","author":"Yang","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0515","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.provac.2010.03.001","article-title":"Validation of indirect ELISA for quantitative testing of rabies antibodies during production of anti-rabies serum using equines","volume":"2","author":"Salvi","year":"2010","journal-title":"Proc Vaccinol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0520","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7589\/0090-3558-24.2.246","article-title":"Measurement of rabies-specific antibodies in carnivores by an enzyme-linked immunosorbent assay","volume":"24","author":"Barton","year":"1988","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0525","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/S0264-410X(00)00127-4","article-title":"ELISA test for rabies antibody titration in orally vaccinated foxes sampled in the fields","volume":"18","author":"Cliquet","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0530","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/S0264-410X(03)00102-6","article-title":"Standardisation and establishment of a rabies ELISA test in European laboratories for assessing the efficacy of oral fox vaccination campaigns","volume":"21","author":"Cliquet","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2003.12.001","article-title":"Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats","volume":"117","author":"Cliquet","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0540","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2006.07.026","article-title":"A quantitative indirect ELISA to monitor the effectiveness of rabies vaccination in domestic and wild carnivores","volume":"318","author":"Servat","year":"2007","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0550","series-title":"International conference on rabies in the Americas (RITA XIX)","first-page":"48","article-title":"Development and validation of ELISA test for detection of rabies anti-glycoprotein antibodies","author":"Mojzis","year":"2008"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0555","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2011.10.019","article-title":"Evaluation of ELISA for detection of rabies antibodies in domestic carnivores","volume":"179","author":"Wasniewki","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0560","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0565","first-page":"281","article-title":"Vaccination against rabies and protective antibodies \u2013 comparison of ELISA and fluorescent antibody virus neutralisation (FAVN) assays","volume":"4","author":"Stantic-Pavlinic","year":"2006","journal-title":"Veterinarski Archiv"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0570","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1099\/jmm.0.006064-0","article-title":"An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies","volume":"58","author":"Welch","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0575","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1017\/S095026880500381X","article-title":"Comparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabies","volume":"133","author":"Balhoul","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0580","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2006.02.011","article-title":"Collaborative study to evaluate a new ELISA test to monitor the effectiveness of rabies vaccination in domestic carnivores","volume":"120","author":"Servat","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0585","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1016\/j.vaccine.2012.06.089","article-title":"Serological methods used for rabies post vaccination surveys: an analysis","volume":"30","author":"De Benedictis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0590","series-title":"Laboratory techniques in rabies","first-page":"200","article-title":"Competitive ELISA for the detection of rabies virus neutralising antibodies","author":"Elmgren","year":"1996"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0595","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/CDLI.4.6.727-730.1997","article-title":"A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs","volume":"4","author":"Sugiyama","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0600","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.vaccine.2009.01.126","article-title":"Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0605","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijid.2006.09.013","article-title":"Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans","volume":"11","author":"Muhamada","year":"2007","journal-title":"Int J Inf Dis"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0610","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0615","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release: use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0620","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1016\/j.vaccine.2013.10.019","article-title":"A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release","volume":"31","author":"Gibert","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0625","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","article-title":"Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor","volume":"86","author":"Sisso\u00ebff","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0630","first-page":"213","article-title":"production of monoclonal antibodies against Pasteur virus (PV strain): problem and results","volume":"57","author":"Libeau","year":"1984","journal-title":"Dev Biol Standard"},{"issue":"Special Issue","key":"10.1016\/j.vaccine.2016.04.086_bib0635","article-title":"Collaborative study for the establishment of human rabies immunoglobulin Biological reference Preparation batch no. 1","author":"Zwahlen","year":"1991","journal-title":"Pharmeuropa"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0640","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/biol.1994.1036","article-title":"Calibration of a replacement preparation for the international standard for rabies immunoglobulin","volume":"22","author":"Lyng","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0645","unstructured":"European Pharmacopoeia. Statistical analysis of results of biological assays and tests; 01\/2008. p. 607."},{"key":"10.1016\/j.vaccine.2016.04.086_bib0650","series-title":"Validation of analytical procedures: text and methodology Q2(R1)","author":"ICH Harmonised Tripartite Guideline","year":"2005"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0655","unstructured":"AFNOR-NF X 06-031-1. Application de la statistique, Cartes de contr\u00f4le, Partie 1: Cartes de contr\u00f4le de Shewhart aux mesures."},{"key":"10.1016\/j.vaccine.2016.04.086_bib0660","unstructured":"Statgraphics\u00ae Centurion XV, StaPoint, Inc. user manual."},{"key":"10.1016\/j.vaccine.2016.04.086_bib0665","series-title":"Technical Report Series 932: Recommendations for the preparation, characterization and establishment of international and other biological reference standards","first-page":"75","author":"WHO","year":"2006"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0670","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/eji.200526134","article-title":"The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries","volume":"35","author":"Kramer","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0675","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel Human Monoclonal Antibody Combination Effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0680","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates","volume":"25","author":"Sloan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0685","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2009.06.018","article-title":"Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library","volume":"161","author":"Houimel","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0690","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1016\/j.vaccine.2009.05.055","article-title":"Peptide mimotopes of rabies virus glycoprotein with immunogenic activity","volume":"27","author":"Houimel","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0695","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00253-012-4171-4","article-title":"Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein","volume":"96","author":"Sun","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0700","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0042-6822(87)90167-X","article-title":"Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies","volume":"161","author":"Dietzschold","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0705","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","article-title":"Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies","volume":"64","author":"Lafon","year":"1983","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0710","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1348-0421.2003.tb03412.x","article-title":"Mapping of the low pH-sensitive conformational epitope of rabies virus glycoprotein recognized by a monoclonal antibody # 1-30-44","volume":"47","author":"Kankanamge","year":"2003","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0715","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biologicals.2009.01.001","article-title":"The rapid fluorescent focus inhibition test is a suitable method batch potency testing of inactivated rabies vaccines","volume":"37","author":"Kr\u00e4mer","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2016.04.086_bib0720","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biologicals.2013.08.003","article-title":"A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use","volume":"41","author":"Kr\u00e4mer","year":"2013","journal-title":"Biologicals"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T05:30:13Z","timestamp":1718515813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":72,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16302614"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}